Reliable Active Pharmaceutical Ingredient Manufacturer Supporting Global Healthcare

Glucosamine Sulfate (CAS 14999-43-0) is an amino monosaccharide with the molecular formula C6H15NO9S and a molecular weight of 277.24 g/mol. Chemically, Glucosamine Sulfate is a sulfate salt of D-glucosamine, consisting of two glucosamine molecules per sulfate group. Glucosamine Sulfate serves as a critical rate-limiting precursor in the biochemical synthesis of glycosylated proteins and lipids.

Sorafenib Tosylate (CAS 475207-59-1) is the tosylate salt of sorafenib, an orally active multikinase inhibitor with the molecular formula C₂₈H₂₄ClF₃N₄O₆S and a molecular weight of 637.03 g/mol. The molecule features a urea-linked diphenyl ether core with a chlorotrifluoromethylphenyl group and a N-methylpyridine-2-carboxamide moiety.

Trametinib (CAS 871700-17-3) is an orally bioavailable, ATP-noncompetitive MEK1/2 inhibitor with the molecular formula C₂₆H₂₃FIN₅O₄ and a molecular weight of 615.39 g/mol. The molecule features a complex pyrido[4,3-d]pyrimidine core with a cyclopropyl group, a fluoro-iodophenylamino substituent, and an acetamide phenyl group.

Nilotinib Hydrochloride (CAS 923288-95-3) is the hydrochloride salt form of nilotinib, an orally bioavailable Bcr-Abl tyrosine kinase inhibitor with the molecular formula C₂₈H₂₃ClF₃N₇O and a molecular weight of 565.98 g/mol. The molecule features a benzamide core with a 4-methyl-1H-imidazol-1-yl group, a trifluoromethyl substituent, and a pyridin-3-yl pyrimidinyl amino group.

Lenvatinib Mesylate (CAS 857890-39-2) is the methanesulfonate salt of lenvatinib, an orally bioavailable, small-molecule multikinase inhibitor with the molecular formula C₂₂H₂₃ClN₄O₇S and a molecular weight of 522.96 g/mol. The molecule features a quinoline carboxamide core with a 3-chloro-4-(3-cyclopropylureido)phenoxy substituent at the 4-position and a methoxy group at the 7-position.

Dasatinib (CAS 302962-49-8) is a potent, oral, multi-targeted tyrosine kinase inhibitor developed as a second-generation Bcr-Abl inhibitor to overcome imatinib resistance. Chemically known as N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, Dasatinib features a complex heterocyclic architecture incorporating a thiazole-5-carboxamide core linked to a chloromethylphenyl group and a pyrimidine-piperazine side chain.